Sickle cell gene therapies offer new hope, but access remains a major challenge

CNBC - Oct 16, 2026

FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.

Read full article
More News

Subscribe Now!

About Us

The Journalist Report publishes timely news updates around the clock. We have a group of journalists around the globe to deliver the latest news around so that we can get our users connected.